Table 1 The baseline characteristics of the study population

From: Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study

Parameters FMT group Control group P value
Total number 10 10
Age(year), M ± SD (range) 51.5 ± 12.7 (32–70) 44.6 ± 14.9(22–75) 0.28
Gender, Female/Male 08-Feb 08-Feb 1.000
Disease duration (year) 5.9 ± 7.3 (0.5–25) 6.9 ± 9.3(0.3–30) 0.777
Disease severity    0.895
 Severe % (n) 50 (5/10) 40(4/10)
 Moderate % (n) 40 (4/10) 50(5/10)
 Mild % (n) 10 (1/10) 10(1/10)
Disease extent    1.000
 Pancolitis % (n) 50 (5/10) 50 (5/10)
 Left-sided colitis % (n) 50 (5/10) 50 (5/10)
Concomitant medications
 Mesalazine 90 (9/10) 100 (10/10)
 Allergy to 5-ASA 10(1/10)
Total Mayo score 9.5 ± 2.5 8.6 ± 2.9 0.462
Endoscopic Mayo score 2.4 ± 0.7 1.9 ± 0.7 0.137